(NASDAQ: RXST) Rxsight's forecast annual revenue growth rate of 1.67% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.
Rxsight's revenue in 2025 is $142,086,000.On average, 13 Wall Street analysts forecast RXST's revenue for 2025 to be $5,419,173,152, with the lowest RXST revenue forecast at $5,140,813,499, and the highest RXST revenue forecast at $5,634,213,179. On average, 13 Wall Street analysts forecast RXST's revenue for 2026 to be $5,645,725,838, with the lowest RXST revenue forecast at $5,250,183,762, and the highest RXST revenue forecast at $6,135,425,021.
In 2027, RXST is forecast to generate $6,202,856,310 in revenue, with the lowest revenue forecast at $5,641,203,008 and the highest revenue forecast at $6,714,758,478.